AirSculpt Technologies (AIRS) Q3 2026 earnings summary

Executive summary

• Q3 results fell short of expectations as weaker marketing productivity and execution issues at several centers weighed on performance; targeted corrective actions are underway.

• Q3 cases fell 10.7% to 2,483 and revenue declined 8.7% to $31.944M; net loss narrowed to $7.173M, while Adjusted EBITDA fell to $0.393M from $3.039M.

• Conversion held steady, and 250 GLP-1-related procedures represented nearly 10% of Q3 cases; management views the service line as an early-stage growth opportunity.

• Same-center sales trends improved 19 percentage points from last year; near-term priorities include stabilizing sales and center execution.

Financial highlights

• Q3 revenue was $31.944M versus $34.993M; nine-month revenue was $114.233M versus $118.376M.

• Q3 net loss was $7.173M versus $9.512M; nine-month net loss was $10.682M versus $12.950M. Q3 diluted loss per share was $0.10 versus $0.15.

• Adjusted EBITDA was $0.393M in Q3 versus $3.039M, and $8.640M for nine months versus $12.629M.

• Gross margin expanded to ~60% from 57.5%, reflecting efficiencies, cost discipline, and the London center closure.

• Q3 SG&A rose to $20.262M from $19.525M, primarily due to higher marketing spend and professional expenses.

Outlook and guidance

• FY2026 revenue guidance was reduced to $144M–$146M from $151M–$157M; Adjusted EBITDA guidance fell to $9M–$10M from $12M–$14M.

• Guidance assumes Q3 trends continue through Q4, including evolving marketing effects from Google AI Overviews and center execution challenges.

• Incremental brand marketing spend is expected to be $3M versus last year, below the $5M indicated last quarter.